PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), 1mg/mL

Produktübersicht

• Artikelname: PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), 1mg/mL
• Artikelnummer: BOT-BNUM2746-50
• Hersteller Artikelnummer: BNUM2746-50
• Alternativnummer: BOT-BNUM2746-50-50UL
• Hersteller: Biotium
• Kategorie: Antikörper
• Applikation: FC, IF, IHC-P, WB

Produktbeschreibung

PD-L1 (also known as Programmed Death Ligand 1, CD274, and B7-H1) is one of two cell surface ligands that engage the negative regulatory T cell surface receptor PD-1. PD-L1 is a Type I transmembrane protein expressed on the plasma membrane of cells, such

Produkteigenschaften

• Konzentration: 1 mg/mL
• Puffer: PBS, no BSA, no azide
• Quelle: Animal